Shanghai Junshi Biosciences Co., Ltd.

SEHK:1877 Stok Raporu

Piyasa değeri: HK$28.3b

Shanghai Junshi Biosciences Yönetim

Yönetim kriter kontrolleri 3/4

Shanghai Junshi Biosciences CEO'su Cong Li, Nov2021 tarihinde atandı, in görev süresi 7.92 yıldır. in toplam yıllık tazminatı CN¥ 4.22M olup, şirket hissesi ve opsiyonları dahil olmak üzere 100% maaş ve 0% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.013% ine doğrudan sahiptir ve bu hisseler HK$ 3.65M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.2 yıl ve 5.4 yıldır.

Anahtar bilgiler

Cong Li

İcra Kurulu Başkanı

CN¥4.2m

Toplam tazminat

CEO maaş yüzdesi100.0%
CEO görev süresi3yrs
CEO sahipliği0.01%
Yönetim ortalama görev süresi3.2yrs
Yönetim Kurulu ortalama görev süresi5.4yrs

Son yönetim güncellemeleri

Recent updates

Shanghai Junshi Biosciences Co., Ltd.'s (HKG:1877) Price Is Right But Growth Is Lacking After Shares Rocket 35%

Oct 14
Shanghai Junshi Biosciences Co., Ltd.'s (HKG:1877) Price Is Right But Growth Is Lacking After Shares Rocket 35%

Is Shanghai Junshi Biosciences (HKG:1877) Using Debt Sensibly?

Sep 30
Is Shanghai Junshi Biosciences (HKG:1877) Using Debt Sensibly?

Shanghai Junshi Biosciences Co., Ltd.'s (HKG:1877) Revenues Are Not Doing Enough For Some Investors

Aug 29
Shanghai Junshi Biosciences Co., Ltd.'s (HKG:1877) Revenues Are Not Doing Enough For Some Investors

Shanghai Junshi Biosciences (HKG:1877) Has Debt But No Earnings; Should You Worry?

Jun 28
Shanghai Junshi Biosciences (HKG:1877) Has Debt But No Earnings; Should You Worry?

Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Fly 27% But Investors Aren't Buying For Growth

May 06
Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Fly 27% But Investors Aren't Buying For Growth

Is Shanghai Junshi Biosciences (HKG:1877) Using Debt Sensibly?

Mar 22
Is Shanghai Junshi Biosciences (HKG:1877) Using Debt Sensibly?

Risks Still Elevated At These Prices As Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Dive 29%

Jan 26
Risks Still Elevated At These Prices As Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Dive 29%

Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?

Dec 17
Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?

Is Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Trading At A 38% Discount?

Nov 20
Is Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Trading At A 38% Discount?

Health Check: How Prudently Does Shanghai Junshi Biosciences (HKG:1877) Use Debt?

Sep 05
Health Check: How Prudently Does Shanghai Junshi Biosciences (HKG:1877) Use Debt?

Revenues Not Telling The Story For Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

May 22
Revenues Not Telling The Story For Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Could Be 35% Below Their Intrinsic Value Estimate

May 01
Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Could Be 35% Below Their Intrinsic Value Estimate

A Look At The Intrinsic Value Of Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Jan 16
A Look At The Intrinsic Value Of Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Some Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 03
Some Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Analysts Just Made A Major Cut To Next Year's Estimates

Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?

Oct 12
Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?

CEO Tazminat Analizi

Cong Li'un ücretlendirmesi Shanghai Junshi Biosciences'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-CN¥2b

Jun 30 2024n/an/a

-CN¥2b

Mar 31 2024n/an/a

-CN¥2b

Dec 31 2023CN¥4mCN¥4m

-CN¥2b

Sep 30 2023n/an/a

-CN¥2b

Jun 30 2023n/an/a

-CN¥2b

Mar 31 2023n/an/a

-CN¥3b

Dec 31 2022CN¥4mCN¥4m

-CN¥2b

Tazminat ve Piyasa: Cong 'ın toplam tazminatı ($USD 588.44K ) Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 506.97K ).

Tazminat ve Kazançlar: Cong şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

Cong Li (60 yo)

3yrs

Görev süresi

CN¥4,224,000

Tazminat

Mr. Cong Li has been Co-Chief Executive Officer and Executive Director at Shanghai Junshi Biosciences Co., Ltd. since November 2, 2021 and served as Non-Executive Director since December 22, 2016 until Nov...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Jun Xiong
Executive Chairman9.7yrsCN¥8.50m13.09%
HK$ 3.7b
Cong Li
Co-CEO & Executive Director3yrsCN¥4.22m0.013%
HK$ 3.7m
Jianjun Zou
GM, CEO & Executive Directorless than a yearCN¥5.86mVeri yok
Ning Li
Executive Vice-Chairman of the Board6.4yrsCN¥9.93m0.0051%
HK$ 1.4m
Baohong Xu
Financial Director4yrsCN¥2.73m0.00071%
HK$ 201.0k
Zhuobing Zhang
Deputy GM & Executive Directorno dataCN¥8.13m0.88%
HK$ 248.6m
Sheng Yao
Senior VP & Executive Directorno dataCN¥8.01mVeri yok
Gang Wang
Deputy GM5.3yrsCN¥1.32m0.0010%
HK$ 288.7k
Xin Li
Executive Directorless than a yearVeri yok0.0096%
HK$ 2.7m
Lu Yuan
Assistant to GM & Chief of Internal Audit Department4yrsVeri yokVeri yok
Qian Wei
Chief Commercial Officer3.3yrsVeri yokVeri yok
Patricia Keegan
Chief Medical Officerno dataVeri yokVeri yok

3.2yrs

Ortalama Görev Süresi

51.5yo

Ortalama Yaş

Deneyimli Yönetim: 1877 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.2 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Jun Xiong
Executive Chairman9.7yrsCN¥8.50m13.09%
HK$ 3.7b
Cong Li
Co-CEO & Executive Director7.9yrsCN¥4.22m0.013%
HK$ 3.7m
Jianjun Zou
GM, CEO & Executive Director2.4yrsCN¥5.86mVeri yok
Ning Li
Executive Vice-Chairman of the Board6.4yrsCN¥9.93m0.0051%
HK$ 1.4m
Zhuobing Zhang
Deputy GM & Executive Director7.9yrsCN¥8.13m0.88%
HK$ 248.6m
Sheng Yao
Senior VP & Executive Director7.9yrsCN¥8.01mVeri yok
Gang Wang
Deputy GM1.1yrsCN¥1.32m0.0010%
HK$ 288.7k
Xin Li
Executive Director1.1yrsVeri yok0.0096%
HK$ 2.7m
Yi Tang
Non-Executive Director9.5yrsVeri yok0.74%
HK$ 209.3m
Chun Zhang
Independent Non-Executive Director4.4yrsCN¥200.00kVeri yok
Xiaoyuan Feng
Independent Non-Executive Director2.9yrsCN¥200.00kVeri yok
Hongyan Kuang
Chairman of the Board of Supervisorsless than a yearVeri yokVeri yok

5.4yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 1877 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.4 yıldır).